Latest news
AbCellera (NASDAQ:ABCL) Shares Surge Ahead of Monday's ABCL635 Phase 2 Trial Results - TechStock²TechStock² · Sat, 08 Aug 2026 14:45:00 GMTViking Therapeutics Moves Closer To Challenging Ozempic With Phase 3 Trial Progress - StocktwitsStocktwits · Sat, 08 Aug 2026 07:43:03 GMTFrom Weight Loss to Liver Normalization: A Deep Dive Into the SYNCHRONIZE-1 Trial Results - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Fri, 07 Aug 2026 12:25:51 GMTSemaglutide Showed Promise in MASH Fibrosis Trial - EMJEMJ · Fri, 07 Aug 2026 09:02:12 GMTInterim Trial Results and Preclinical Data Highlight Potential of ABS-201 in Androgenetic Alopecia - Dermatology TimesDermatology Times · Thu, 06 Aug 2026 18:09:33 GMTIDEAYA Biosciences (IDYA) Stock Could Be Fully Valued After Trial Progress - simplywall.stsimplywall.st · Thu, 06 Aug 2026 16:35:29 GMTHow Beam’s Wider Q2 Loss and Trial Progress Will Impact Beam Therapeutics (BEAM) Investors - simplywall.stsimplywall.st · Thu, 06 Aug 2026 14:40:00 GMTBeirut Port blast victims' families gather inside port area; Justice & Information Ministers pledge indictment, trial progress - Alliance of Mediterranean News Agencies (AMAN)Alliance of Mediterranean News Agencies (AMAN) · Wed, 05 Aug 2026 08:59:03 GMT